Westfield Capital Management
GSK icon

Westfield Capital Management’s GSK GSK Stock Holding History

Westfield Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-125,472
Closed -$6.03M – 283
2015
Q3 		$6.03M Buy
125,472
+37,064
+42% +$1.93M 0.04% 202
2015
Q2 		$4.6M Buy
88,408
+5,912
+7% +$333K 0.03% 237
2015
Q1 		$4.76M Buy
82,496
+17,000
+26% +$975K 0.03% 246
2014
Q4 		$3.5M Buy
65,496
+13,104
+25% +$733K 0.02% 249
2014
Q3 		$3.01M Buy
+52,392
New +$3.21M 0.02% 243
2014
Q2 		– Sell
-17,640
Closed -$1.18M – 328
2014
Q1 		$1.18M Buy
17,640
+1,224
+7% +$82.7K 0.01% 280
2013
Q4 		$1.1M Buy
16,416
+400
+2% +$25.9K 0.01% 274
2013
Q3 		$1M Hold
16,016
– – 0.01% 286
2013
Q2 		$1M Buy
+16,016
New +$1.02M 0.01% 286

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Westfield Capital Management's GSK Position: Q4 2015 in Review

Westfield Capital Management sold out of GSK (GSK) in Q4 2015, closing a stake of 125,472 shares — an estimated $6.03M sold.

Westfield Capital Management first reported a position in GSK in Q2 2013 and held it in 9 quarters. The position peaked at $6.03M in Q3 2015. 718 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

  • Westfield Capital Management reported no remaining GSK position as of Q4 2015 after selling out during the quarter.
  • Westfield Capital Management sold 125,472 GSK shares in Q4 2015, an estimated $6.03M.
  • Westfield Capital Management first reported a position in GSK in Q2 2013 and held it in 9 quarters.
  • Westfield Capital Management's GSK position peaked at $6.03M in Q3 2015.
  • 718 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on Westfield Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.